Hinge Health, Inc.
$43.93
▲
1.27%
2026-04-21 07:19:01
www.hingehealth.com
NYQ: HNGE
Explore Hinge Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.41 B
Current Price
$43.93
52W High / Low
$62.18 / $30.08
Stock P/E
—
Book Value
$2.26
Dividend Yield
—
ROCE
-142.9%
ROE
-1.33%
Face Value
—
EPS
$-7.77
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
1,437
Beta
—
Debt / Equity
2.12
Current Ratio
1.47
Quick Ratio
1.43
Forward P/E
15.37
Price / Sales
4.74
Enterprise Value
$2.63 B
EV / EBITDA
-4.84
EV / Revenue
4.48
Rating
Buy
Target Price
$57.94
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Omnicell, Inc. | $37.8 | 839.18 | $1.72 B | — | 0.34% | 0.17% | $55 / $22.66 | $27.36 |
| 2. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
| 3. | Zhongchao Inc. | $2.06 | — | $7.52 M | — | -1.4% | -24.88% | $12.18 / $1.44 | $6.39 |
| 4. | Spok Holdings, Inc. | $11.48 | 14.99 | $237.98 M | 10.89% | 12.85% | 10.55% | $19.31 / $10.81 | $7.1 |
| 5. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 6. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 7. | Privia Health Group, Inc. | $24.08 | 131.66 | $3.02 B | — | 4.27% | 4.03% | $26.51 / $18.77 | $5.96 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 170.73 M | 154.21 M | 139.1 M | 123.83 M | — | — |
| Operating Profit | 27.26 M | -6.09 M | -580.67 M | 13.14 M | — | — |
| Net Profit | 32.09 M | -1.84 M | -575.65 M | 17.14 M | — | — |
| EPS in Rs | 0.58 | -0.03 | -10.31 | 0.31 | — | 0 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 587.86 M | 390.4 M | 292.73 M |
| Operating Profit | -546.37 M | -31.91 M | -130.51 M |
| Net Profit | -528.26 M | -11.93 M | -108.14 M |
| EPS in Rs | -9.46 | -0.21 | -1.94 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 744.76 M | 673.26 M | 622.53 M |
| Total Liabilities | 366.23 M | 256.56 M | 195.25 M |
| Equity | 378.54 M | 416.7 M | 427.28 M |
| Current Assets | 533.9 M | 583.45 M | 529.88 M |
| Current Liabilities | 362.41 M | 249.3 M | 184.16 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | 171.44 M | 49 M | -63.91 M |
| Investing CF | -113.76 M | 18.31 M | 1.5 M |
| Financing CF | -150.47 M | -2.2 M | -3 M |
| Free CF | 165.38 M | 45.23 M | -68.52 M |
| Capex | -6.06 M | -3.77 M | -4.62 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | 50.58% | 33.37% | — |
| Earnings Growth % | -4326.89% | 88.97% | — |
| Profit Margin % | -89.86% | -3.06% | -36.94% |
| Operating Margin % | -92.94% | -8.17% | -44.59% |
| Gross Margin % | 79.65% | 76.82% | 66.33% |
| EBITDA Margin % | -92.07% | -6.65% | -42.66% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.